SEC Form 4 · accession 0001666236-26-000022
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve E. Krognes
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 6:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | M | 155 | $0.00 | A | 14,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jun 30, 2026 | M | 155 | D | — | — | Common Stock | 155 | 0 | D |
Explanation of responses
- F1This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter.
- F2Not applicable for Restricted Stock Units.